Inspections, Compliance, Enforcement, and Criminal Investigations
Reiland, James Close out Letter 12/19/11
| Public Health Service Food and Drug Administration |
| Minneapolis District Office Central Region 250 Marquette Avenue, Suite 600 Minneapolis, MN 55401 Telephone: (612) 758-7210 FAX: (612) 334-4142 |
December 19, 2011
James M. Reiland
Owner
N4212 Meade Street
Appleton, Wisconsin 54913
Dear Mr. Reiland:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter MIN 12-05 dated November 15, 2011. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Demetria L. Lueneburg
Compliance Officer
Minneapolis District





Department of Health and Human Services

